IP-6 (Inositol Hexaphosphate)
What the trials found
IP-6 does not establish a usable benefit for blood sugar, inflammation, or general metabolic support in humans because the available evidence is too sparse and unquantified.
- 2 papers
- 0 of 7 outcomes
- 1 severe
Risk, worst reported severity
- hypoglycemia severe
- cyclophosphamide moderate
Dose, timing & forms
How much
The reviewed evidence does not provide an evidence-backed IP-6 dose for metabolic health or inflammation. Avoid treating a label dose as proven just because it appears precise. A number on a bottle is not the same thing as a tested, useful protocol.
When and how long
No reliable trial-based timing routine stands out for IP-6. Do not assume that taking it with meals, away from meals, in the morning, or at night improves results until stronger human research tests those choices.
Forms & standardisation
Look for a label that clearly identifies the ingredient as IP-6, inositol hexaphosphate, or phytic acid. No specific extract, mineral complex, or added inositol blend has enough reviewed human evidence to earn a preferred-form recommendation.
Adverse events and drug interactions
Safety events
Drug interactions
What this is and how it works
- Two papers spanning seven outcomes provide no pooled sample size or quantified effect estimate for meaningful benefit.
- Human evidence reviewed here covers blood sugar, inflammation, and broader metabolic outcomes without a clearly supported dose or population.
- Reported severe hypoglycemia warrants caution for people with low blood sugar or medicines affecting glucose.
IP-6 is short for inositol hexaphosphate, also known as phytic acid. It occurs naturally in plant foods, especially seeds, legumes, nuts, and whole grains, where it stores phosphorus for the growing plant.1
IP-6 carries several tightly packed phosphate groups that grab onto positively charged mineral ions, much like a cargo net catching metal balls. That mineral-binding chemistry can change how minerals behave in food and in the gut, but it does not establish a meaningful supplement benefit in people.1
Bottom line
IP-6 is not a smart first pick for blood sugar, inflammation, or general metabolic support because the reviewed human evidence has not established a usable benefit. Avoid self-experimenting if you have a history of low blood sugar, and get clinician guidance before use if you take medicines or manage a chronic condition. The reported risk of severe hypoglycemia is a reason for real caution, not casual stacking.
Common questions
What is IP-6?
Does IP-6 support healthy blood sugar?
Is IP-6 the same as phytic acid?
Sources
Sources
Generated August 27, 2026
Related